CASEY LONG: Open Payments
NPI 1609284751 · MONTGOMERY, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$727 in 52 payments from 13 companies in 2025. Trend: 2023 $1,271 · 2024 $1,083 · 2025 $727
Food & beverage: $727
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $190 |
| Boston Scientific Corporation | 12 | $139 |
| Indivior Inc. | 3 | $89 |
| AstraZeneca Pharmaceuticals LP | 5 | $77 |
| Exact Sciences Corporation | 4 | $60 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $39 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| Braeburn Inc. | 1 | $23 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Teleflex LLC | 1 | $17 |
Products named: Infinion 16, SUBLOCADE, UBRELVY, Cologuard Collection Kit, VRAYLAR, QULIPTA, Kerendia, AIRSUPRA.
Industry payments across AL — which companies pay providers there.
